View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | United States |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2028-11-15 |
| Par Value | 100000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 72.11 |
| Coupon | 2.625 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 500.000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Allergan Funding SCS. corporate note has a 2.63% fixed rate coupon paid on a annual basis. It was issued on November 15, 2018 with an issue size of 500.00 million EUR and matures on November 15, 2028 with a last coupon date of November 15, 2027. |
Allergan Funding SCS, headquartered in Luxembourg, was founded to facilitate financing for its parent company, Allergan, in the healthcare sector. The company focuses primarily on raising capital through bond issuance to support Allergan's various business operations and product developments.